CD4 and neoplasm: In the present study, enhanced anti-tumor immunity was observed in tumor lesions of tumor-bearing mice treated with IMQ combined with IR, and this conclusion was supported by increased frequencies of CD4+ and CD8+ T cells in association with reduced frequencies of Treg and MDSC populations in tumor foci.